Group 1 - The core message emphasizes the importance of integrating medical innovation research with the biopharmaceutical industry in Shanghai, aiming to create a world-class life sciences innovation ecosystem [1][3] - The Shanghai Jiao Tong University School of Medicine's new campus, a significant project, has been completed after four years of construction and will officially begin operations [3] - The city government aims to leverage the advantages of the Pudong New Area and the research strengths of the university to enhance the entire chain from basic research to clinical validation and industrial transformation [3][5] Group 2 - A signing ceremony was held between Pudong New District and Shanghai Jiao Tong University, focusing on collaboration in areas such as cutting-edge technology innovation, discipline construction, and talent cultivation [5] - The city government expresses ongoing support for the development of Shanghai Jiao Tong University and its medical school, aiming to foster a mutually beneficial relationship between the city and the university [3][5]

在调研活动前，龚正出席浦东新区与上海交通大学、上海交通大学医学院签约仪式。 作为上海市重大工程项目，上海交通大学医学院浦东校区历经4年建设，今年如期竣工并将正式投入使 用。下午，龚正来到交大医学院浦东校区，详细了解新校区功能布局以及医学院发展情况。随后，龚正 走进图书馆，察看馆内设施及馆藏特色书籍，并来到实验动物科学部，了解平台建设和管理情况。在交 大医学院"医谷"和上海市病毒研究院，龚正详细了解相关重点研究平台开展科研攻关、促进创新转化等 情况。 龚正指出，上海交通大学医学院是全国医学教育改革与发展的排头兵。希望交大医学院胸怀"国之大 者"，勇担时代使命，下好区校合作、产医融合这盘大棋。希望用好浦东引领区的政策优势和产业优 势，叠加交大医学院的科研优势、人才优势，高标准构建从基础研究、临床验证到产业转化的全链条， 打通成果转化的"最后一公里"，为上海建设世界级生物医药产业集群提供助力。希望在医学研究领域实 现新突破，以建设全国重点实验室、研究院等高能级平台为契机，培养集聚顶尖人才和创新团队，营造 开放协同的科研生态，努力产出更多原创性成果。市委、市政府将一如既往地支持上海交通大学及交大 医学院的建设发展，谱 ...

Core Viewpoint - The "Three-Year Action Plan for Integrated Development of Health and Wellness in the Yangtze River Delta (2025-2027)" aims to enhance medical technology innovation, industry collaboration, international cooperation, and governance mechanisms in the health sector [1][2]. Group 1: Key Areas of Focus - The action plan includes seven key areas: improving the homogeneity of medical technology capabilities, enhancing public health safety, promoting medical technology innovation and pharmaceutical industry development, deepening integrated health governance, and optimizing support mechanisms for internationalization [2][3]. - The plan emphasizes the establishment of national regional medical centers, mutual recognition of inspection results, and the creation of specialized disease alliances to improve medical service quality [2][4]. Group 2: Industry Collaboration - The action plan encourages the development of a biopharmaceutical industry characterized by regional collaboration, requiring the three provinces and one city to leverage their respective advantages for industry deployment and cooperation [3][5]. - It supports the creation of a "technology innovation community" and cross-regional collaboration on clinical projects to facilitate the commercialization of scientific achievements [4][6]. Group 3: Internationalization Efforts - The plan highlights the importance of internationalization, proposing the establishment of an international medical alliance and high-level open platforms for healthcare [5][6]. - It aims to integrate high-quality medical resources and traditional Chinese medicine advantages to position the Yangtze River Delta as a high-end health tourism destination, promoting a dual-directional international cooperation model [6].